definiens: shall mean the gross amount invoiced by a Party, its Affiliates, or sublicensees for sales, transfer ordisposition to independent, unrelated Third Parties of a Collaboration Product ( such Collaboration Product being in the finalform intended for use by the end user ), during such time period ( including the fair market value of all other considerationreceived for the sale, transfer or other disposition of a Collaboration Product by a Party, its Affiliates, or sublicensees, whethersuch consideration is in cash, payments in kind, exchange or other forms ), exclusive of ( i ) inter - company transfers or sales toor from its Affiliates or sublicensees, ( ii ) transfers of samples of the Collaboration Product such as for physician samples andindigent patient and similar programs ( including registration samples ), and ( iii ) transfers of the Collaboration Product for usein post - launch Clinical Studies, less the Permitted Deductions . The Permitted Deductions shall include only the following, tothe extent each is actually incurred and is not otherwise recovered by or reimbursed to [COMPANY] or HGS, its Affiliates, orsublicensees ( which are to be determined under generally accepted accounting principles ( ) in the United States ) anddoes not exceed the reasonable and customary amount for such item in the market in which the sale occurred : ( a ) trade, cash and quantity discounts or rebates on any Collaboration Products ; ( b ) credits, allowances, rebates or chargebacks given or made to a customer for retroactive price reductions ( includingrebates similar to Medicaid ) ; [ * * * ] INDICATES MATERIAL THAT HAS BEEN OMITTED AND FOR WHICH CONFIDENTIAL TREATMENT HASBEEN REQUESTED . ALL SUCH OMITTED MATERIAL HAS BEEN FILED WITH THE SECURITIES ANDEXCHANGE COMMISSION PURSUANT TO RULE 24b-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934,AS AMENDED